Junji Yamashita

Summary

Country: Japan

Publications

  1. doi request reprint Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats
    Junji Yamashita
    Pharmaceutical Research Laboratory, Research Division, Nihon Pharmaceutical Co Ltd, Narita City, Chiba, Japan
    Eur J Pharmacol 589:239-44. 2008
  2. doi request reprint Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells
    Tetsumasa Sasaoka
    Pharmaceutical Research Laboratory, Research Division, Nihon Pharmaceutical, Co Ltd, Sumiyoshichou, Izumisano, Osaka, Japan
    Am J Physiol Gastrointest Liver Physiol 300:G568-76. 2011
  3. doi request reprint Murine Schnurri-2 controls natural killer cell function and lymphoma development
    Junji Yamashita
    Department of Immunology, Graduate School of Medicine, Chiba University, Chuo Ku, Chiba, Japan
    Leuk Lymphoma 53:479-86. 2012
  4. ncbi request reprint Role of Na+/H+ exchanger in the pathogenesis of ischemic acute renal failure in mice
    Junji Yamashita
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan
    J Cardiovasc Pharmacol 49:154-60. 2007
  5. ncbi request reprint A novel mouse model for MPO-ANCA-associated glomerulonephritis
    Wako Yumura
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Japan
    Microbiol Immunol 50:149-57. 2006
  6. ncbi request reprint A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury
    Masaya Ogata
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4 20 1 Nasahara, Takatsuki, Osaka 569 1094, Japan
    Eur J Pharmacol 478:187-98. 2003
  7. ncbi request reprint Role of nitric oxide in the renal protective effects of ischemic preconditioning
    Junji Yamashita
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Japan
    J Cardiovasc Pharmacol 42:419-27. 2003
  8. ncbi request reprint Attenuation of ischemia/reperfusion-induced renal injury in mice deficient in Na+/Ca2+ exchanger
    Junji Yamashita
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Osaka, Japan
    J Pharmacol Exp Ther 304:284-93. 2003
  9. ncbi request reprint Role of endothelin B receptor in the pathogenesis of ischemic acute renal failure
    Masahiro Nishida
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Osaka, Japan
    J Cardiovasc Pharmacol 40:586-93. 2002
  10. ncbi request reprint Pathophysiological roles of Ca(2+) overload via the Na(+)/Ca(2+) exchanger and endothelin-1 overproduction in ischaemia/reperfusion-induced acute renal failure
    Yasuo Matsumura
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4 20 1 Nasahara, Takatsuki, Osaka 569 1094, Japan
    Clin Sci (Lond) 103:389S-392S. 2002

Collaborators

  • Toshinori Nakayama
  • T Iwamoto
  • W Yumura
  • Yasuo Matsumura
  • Tetsumasa Sasaoka
  • Masaya Ogata
  • Masanori Takaoka
  • Masahiro Nishida
  • Masayuki Ito
  • Kenji Kaneko
  • Kenji Nakajima
  • Hitoshi Tanaka
  • Yoshiaki Kaneshiro
  • Munehisa Takahashi
  • Yukio Hara
  • Issei Tanaka
  • Takato Matsuo
  • Kaori Hada
  • Masakuni Narita
  • Youichi Ohno
  • Naoko Tazawa
  • Mitsunori Nishikawa
  • Issei Komuro
  • Miyuki Ieshima
  • Satomi Kita
  • Munekazu Shigekawa
  • Fumiko Konishi
  • Koji Wakimoto

Detail Information

Publications10

  1. doi request reprint Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats
    Junji Yamashita
    Pharmaceutical Research Laboratory, Research Division, Nihon Pharmaceutical Co Ltd, Narita City, Chiba, Japan
    Eur J Pharmacol 589:239-44. 2008
    ..These findings suggest that thrombin plays an important role in the pathogenesis of puromycin aminonucleoside-induced nephrotic syndrome. Treatment with antithrombin may be clinically effective in patients with nephrotic syndrome...
  2. doi request reprint Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells
    Tetsumasa Sasaoka
    Pharmaceutical Research Laboratory, Research Division, Nihon Pharmaceutical, Co Ltd, Sumiyoshichou, Izumisano, Osaka, Japan
    Am J Physiol Gastrointest Liver Physiol 300:G568-76. 2011
    ..These results suggest new possible therapeutic approaches for IBD, including disorders such as Crohn's disease and ulcerative colitis...
  3. doi request reprint Murine Schnurri-2 controls natural killer cell function and lymphoma development
    Junji Yamashita
    Department of Immunology, Graduate School of Medicine, Chiba University, Chuo Ku, Chiba, Japan
    Leuk Lymphoma 53:479-86. 2012
    ..Thus, Shn-2 is considered to play an important role in the activation and function of NK cells and the development of T cell lymphoma in vivo...
  4. ncbi request reprint Role of Na+/H+ exchanger in the pathogenesis of ischemic acute renal failure in mice
    Junji Yamashita
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan
    J Cardiovasc Pharmacol 49:154-60. 2007
    ..The inhibition of NHE by EIPA may be considered as a therapeutic approach to protect the postischemic ARF...
  5. ncbi request reprint A novel mouse model for MPO-ANCA-associated glomerulonephritis
    Wako Yumura
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Japan
    Microbiol Immunol 50:149-57. 2006
    ..These findings indicate that BSA induces neutrophil activation of peripheral blood followed by the elevation of MPO-ANCA, resulting in the development of crescentic glomerulonephritis in mice...
  6. ncbi request reprint A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury
    Masaya Ogata
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4 20 1 Nasahara, Takatsuki, Osaka 569 1094, Japan
    Eur J Pharmacol 478:187-98. 2003
    ..The possibility exists that a selective Na+/Ca2+ exchange inhibitor such as SEA0400 is useful as effective therapeutic agent against ischemic acute renal failure in humans...
  7. ncbi request reprint Role of nitric oxide in the renal protective effects of ischemic preconditioning
    Junji Yamashita
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Japan
    J Cardiovasc Pharmacol 42:419-27. 2003
    ....
  8. ncbi request reprint Attenuation of ischemia/reperfusion-induced renal injury in mice deficient in Na+/Ca2+ exchanger
    Junji Yamashita
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Osaka, Japan
    J Pharmacol Exp Ther 304:284-93. 2003
    ....
  9. ncbi request reprint Role of endothelin B receptor in the pathogenesis of ischemic acute renal failure
    Masahiro Nishida
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Osaka, Japan
    J Cardiovasc Pharmacol 40:586-93. 2002
    ..Thus, ET receptor-mediated actions do not play an important role in the development of ischemic ARF but may be involved in the recovery process from ischemia/reperfusion-induced renal injury...
  10. ncbi request reprint Pathophysiological roles of Ca(2+) overload via the Na(+)/Ca(2+) exchanger and endothelin-1 overproduction in ischaemia/reperfusion-induced acute renal failure
    Yasuo Matsumura
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4 20 1 Nasahara, Takatsuki, Osaka 569 1094, Japan
    Clin Sci (Lond) 103:389S-392S. 2002
    ..We conclude that Ca(2+) overload via the reverse-mode of Na(+)/Ca(2+) exchange, followed by renal ET-1 overproduction, plays an important role in the pathogenesis of ischaemia/reperfusion-induced acute renal failure...